Alcon
Alcon is a global eye care company operating across ophthalmic surgical and vision care markets. The company develops, manufactures and commercializes surgical devices, intraocular lens materials, contact lenses and ocular pharmaceuticals, and maintains a global R&D pipeline and manufacturing footprint. Alcon reports multi‑billion USD annual sales, invests in R&D, operates manufacturing sites worldwide, and conducts global regulatory and post‑market quality activities.
Industries
Nr. of Employees
Very Large (1000+)
Alcon
Patents
High power femtosecond laser with repetition rate adjustable according to scanning speed
US-8953651-B2
View Details
High power femtosecond laser with repetition rate adjustable according to scanning speed
US-8953651-B2
View DetailsProducts
Surgical platforms and instruments
A range of ophthalmic surgical systems and instruments for cataract, retinal and refractive procedures, as well as related consumables and surgical solutions.
Contact lenses and lens‑care products
Daily‑disposable and reusable contact lenses across multiple material technologies, and lens‑care solutions for cleaning and maintenance.
Ophthalmic pharmaceuticals and drug candidates
Commercial ophthalmic drug products and an active pharmaceutical pipeline, including late‑stage candidates for dry eye and glaucoma therapies.
TOTAL30® MULTIFOCAL FOR ASTIGMATISM
Monthly replacement contact lenses that approach 100% water at the surface to provide a gentle cushion of moisture.
AIR OPTIX plus HydraGlyde for ASTIGMATISM
Breathable reusable monthly replacement contact lenses featuring SmartShield Technology and HydraGlyde Moisture Matrix for continuous hydration and deposit protection.
NIGHT & DAY AQUA
Comfortable continuous wear contact lenses for people with busy lifestyles who need a flexible lens-wearing experience.
Surgical platforms and instruments
A range of ophthalmic surgical systems and instruments for cataract, retinal and refractive procedures, as well as related consumables and surgical solutions.
Contact lenses and lens‑care products
Daily‑disposable and reusable contact lenses across multiple material technologies, and lens‑care solutions for cleaning and maintenance.
Ophthalmic pharmaceuticals and drug candidates
Commercial ophthalmic drug products and an active pharmaceutical pipeline, including late‑stage candidates for dry eye and glaucoma therapies.
TOTAL30® MULTIFOCAL FOR ASTIGMATISM
Monthly replacement contact lenses that approach 100% water at the surface to provide a gentle cushion of moisture.
AIR OPTIX plus HydraGlyde for ASTIGMATISM
Breathable reusable monthly replacement contact lenses featuring SmartShield Technology and HydraGlyde Moisture Matrix for continuous hydration and deposit protection.
NIGHT & DAY AQUA
Comfortable continuous wear contact lenses for people with busy lifestyles who need a flexible lens-wearing experience.
Services
Commercial manufacture, marketing and distribution of surgical devices, contact lenses, lens care solutions and ophthalmic pharmaceuticals.
Internal R&D platforms and centers of excellence for device, material and pharmaceutical development.
Commercial manufacture, marketing and distribution of surgical devices, contact lenses, lens care solutions and ophthalmic pharmaceuticals.
Internal R&D platforms and centers of excellence for device, material and pharmaceutical development.
Expertise Areas
- Ophthalmic surgical systems
- Contact lens formulation and manufacturing
- Intraocular lens biomaterials
- Ophthalmic pharmaceutical development
Key Technologies
- Phacoemulsification surgical platforms
- Intraoperative aberrometry and image‑guided biometry
- 3D surgical visualization systems
- Water‑gradient and silicone hydrogel contact lens materials
News & Updates
Acquisition expanded Alcon's ophthalmic pharmaceutical portfolio and added research and development capabilities and late‑stage product candidates.
Entered settlement agreement resolving intellectual property disputes related to femtosecond laser assisted cataract surgery devices; included cross‑licenses and a one‑time payment.
Featured opinion piece on World Sight Day and the importance of investing in eye care professionals.
First healthcare company to be certified for Zero Waste to Landfill operations for select sites.
Acquisition expanded Alcon's ophthalmic pharmaceutical portfolio and added research and development capabilities and late‑stage product candidates.
Entered settlement agreement resolving intellectual property disputes related to femtosecond laser assisted cataract surgery devices; included cross‑licenses and a one‑time payment.
Featured opinion piece on World Sight Day and the importance of investing in eye care professionals.
First healthcare company to be certified for Zero Waste to Landfill operations for select sites.